Yolanda Fernández
- Cancer Research top 10%
- Oncology top 5%
- Cancer Treatment and Pharmacology 9
- Lung Cancer Research Studies 7
- Cancer Cells and Metastasis 5
- HER2/EGFR in Cancer Research 5
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 7
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 3
- Clinical Psychology top 10%
-
- Lung Cancer Treatments and Mutations 6
-
- Nanoplatforms for cancer theranostics 4
- Co-authors
- Simó SchwartzDana AndersonWilliam L. MarshallIbane AbasoloSantiago Ramón y CajalEloy EspínJosep TaberneroIsabel Puig
- Cited by
- Cancer ResearchOncologyBiomaterials
- Journals
- Journal of Biological Chemistry (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (3 papers)
- Partner nations
- SpainPortugalPalestinian Territory
In The Last Decade
Yolanda Fernández
54 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 263
- Oncology 461
- Biomaterials 210
- Molecular Biology 705
- Clinical Psychology 193
Countries citing papers authored by Yolanda Fernández
This map shows the geographic impact of Yolanda Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda Fernández more than expected).
Fields of papers citing papers by Yolanda Fernández
This network shows the impact of papers produced by Yolanda Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda Fernández. The network helps show where Yolanda Fernández may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yolanda Fernández, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2018 | 53 | |
| 5 | 2018 | 11 | |
| 6 | 2018 | 73 | |
| 7 | 2017 | 3 | |
| 8 | Investigation of the role of cysteinyl leukotrienes in ocular developmental angiogenesis | 2016 | 1 |
| 9 | 2014 | 30 | |
| 10 | 2013 | 18 | |
| 11 | 2013 | 27 | |
| 12 | 2012 | 37 | |
| 13 | 2011 | 33 | |
| 14 | 2011 | 24 | |
| 15 | 2009 | 8 | |
| 16 | 2009 | 54 | |
| 17 | 2007 | 16 | |
| 18 | 2006 | 6 | |
| 19 | 2005 | 13 | |
| 20 | 2003 | 47 |
About Yolanda Fernández
Yolanda Fernández is a scholar working on Oncology, Biomaterials and Cancer Research, having authored 58 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Nanoparticle-Based Drug Delivery (7 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Cells and Metastasis (5 papers), HER2/EGFR in Cancer Research (5 papers), Nanoplatforms for cancer theranostics (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Cancer Research (263 citations), Oncology (461 citations) and Biomaterials (210 citations). Yolanda Fernández has collaborated with scholars based in Spain, Portugal and Palestinian Territory. Frequent co-authors include Simó Schwartz, Dana Anderson, William L. Marshall, Ibane Abasolo, Santiago Ramón y Cajal, Eloy Espín, Josep Tabernero, Isabel Puig, José Raúl Herance and Paloma Ordóñez‐Morán. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.